Treatment of Liver Tumors with Transarterial Chemoembolization.
作者信息
Poliektov Natalie, Johnson D Thor
机构信息
Department of Radiology, University of Colorado College of Medicine, Aurora, Colorado.
出版信息
Semin Intervent Radiol. 2018 Oct;35(4):350-355. doi: 10.1055/s-0038-1673423. Epub 2018 Nov 5.
Abstract
摘要
相似文献
1
Treatment of Liver Tumors with Transarterial Chemoembolization.
Semin Intervent Radiol. 2018 Oct;35(4):350-355. doi: 10.1055/s-0038-1673423. Epub 2018 Nov 5.
2
Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
J Vasc Interv Radiol. 2013 Jun;24(6):805-12. doi: 10.1016/j.jvir.2013.01.499. Epub 2013 Apr 4.
3
Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation.
Transplant Proc. 2018 Nov;50(9):2622-2625. doi: 10.1016/j.transproceed.2018.05.012. Epub 2018 May 24.
4
Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases.
J Vasc Interv Radiol. 2016 Sep;27(9):1298-1304. doi: 10.1016/j.jvir.2016.05.014. Epub 2016 Aug 4.
5
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7.
6
Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
J Vasc Interv Radiol. 2019 Dec;30(12):1879-1886. doi: 10.1016/j.jvir.2019.07.029. Epub 2019 Oct 24.
7
Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.
J Vasc Interv Radiol. 2018 Apr;29(4):540-549.e4. doi: 10.1016/j.jvir.2017.11.033. Epub 2018 Feb 22.
8
Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: A meta-analysis.
J Gastroenterol Hepatol. 2017 Jul;32(7):1286-1294. doi: 10.1111/jgh.13727.
9
A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.
10
Bridging Hepatocellular Carcinoma to Transplant: Transarterial Chemoembolization Response, Tumor Biology, and Recurrence after Transplantation in a 12-Year Transplant Cohort.
J Vasc Interv Radiol. 2019 Jul;30(7):995-1003. doi: 10.1016/j.jvir.2018.12.736. Epub 2019 May 17.
引用本文的文献
1
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
本文引用的文献
1
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
Cancer. 2016 May 1;122(9):1312-37. doi: 10.1002/cncr.29936. Epub 2016 Mar 9.
2
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
3
Chemoembolization of hepatocellular carcinoma.
Semin Intervent Radiol. 2013 Mar;30(1):3-11. doi: 10.1055/s-0033-1333648.
4
Embolization of liver tumors: Past, present and future.
World J Radiol. 2012 Sep 28;4(9):405-12. doi: 10.4329/wjr.v4.i9.405.
5
Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
Liver Transpl. 2013 Feb;19(2):164-73. doi: 10.1002/lt.23552. Epub 2012 Dec 12.
6
Current status of embolic agents for liver tumor embolization.
Int J Clin Oncol. 2012 Aug;17(4):306-15. doi: 10.1007/s10147-012-0445-1. Epub 2012 Jul 18.
7
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
8
Transarterial chemoembolization for hepatocellular carcinoma over three decades: current progress and perspective.
Jpn J Clin Oncol. 2012 Apr;42(4):247-55. doi: 10.1093/jjco/hys020. Epub 2012 Mar 9.
9
Management of hepatocellular carcinoma: an update.
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.
10
The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Korean J Radiol. 2009 Sep-Oct;10(5):425-34. doi: 10.3348/kjr.2009.10.5.425. Epub 2009 Aug 25.
Zotero 插件